CN102070626A - 一种制备伊潘立酮的新方法 - Google Patents
一种制备伊潘立酮的新方法 Download PDFInfo
- Publication number
- CN102070626A CN102070626A CN2010106057715A CN201010605771A CN102070626A CN 102070626 A CN102070626 A CN 102070626A CN 2010106057715 A CN2010106057715 A CN 2010106057715A CN 201010605771 A CN201010605771 A CN 201010605771A CN 102070626 A CN102070626 A CN 102070626A
- Authority
- CN
- China
- Prior art keywords
- preferred
- zomaril
- preparation
- reaction
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XMXHEBAFVSFQEX-UHFFFAOYSA-N iloperidone Chemical compound COC1=CC(C(C)=O)=CC=C1OCCCN1CCC(C=2C3=CC=C(F)C=C3ON=2)CC1 XMXHEBAFVSFQEX-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 229960003162 iloperidone Drugs 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- 238000002360 preparation method Methods 0.000 claims description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 14
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000012046 mixed solvent Substances 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- 235000015320 potassium carbonate Nutrition 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- 235000007715 potassium iodide Nutrition 0.000 claims description 5
- 229960004839 potassium iodide Drugs 0.000 claims description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 2
- -1 p-toluenesulfonyl Chemical group 0.000 claims description 2
- 238000007039 two-step reaction Methods 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- 239000003513 alkali Substances 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000007530 organic bases Chemical class 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 3
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- 235000010755 mineral Nutrition 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 230000035484 reaction time Effects 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- KEIQPPQTKPFHLZ-UHFFFAOYSA-N 3-piperidin-4-yl-1,2-benzoxazole Chemical compound C1CNCCC1C1=NOC2=CC=CC=C12 KEIQPPQTKPFHLZ-UHFFFAOYSA-N 0.000 claims 1
- GVMQXMFLUSCQJS-UHFFFAOYSA-N 4-fluoro-3-piperidin-4-yl-1,2-benzoxazole Chemical compound C1=2C(F)=CC=CC=2ON=C1C1CCNCC1 GVMQXMFLUSCQJS-UHFFFAOYSA-N 0.000 claims 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Inorganic materials [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 claims 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims 1
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims 1
- CFHIDWOYWUOIHU-UHFFFAOYSA-N oxomethyl Chemical compound O=[CH] CFHIDWOYWUOIHU-UHFFFAOYSA-N 0.000 claims 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 1
- 235000017550 sodium carbonate Nutrition 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- 229940073735 4-hydroxy acetophenone Drugs 0.000 abstract description 5
- 239000000047 product Substances 0.000 abstract description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 4
- 239000006227 byproduct Substances 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 2
- 238000006467 substitution reaction Methods 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000007787 solid Substances 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 7
- 239000012074 organic phase Substances 0.000 description 7
- 238000001035 drying Methods 0.000 description 5
- 235000019439 ethyl acetate Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000010189 synthetic method Methods 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- YUKUDJRCHPSDGC-UHFFFAOYSA-N 1,2-oxazole;hydrochloride Chemical compound Cl.C=1C=NOC=1 YUKUDJRCHPSDGC-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000006103 sulfonylation Effects 0.000 description 1
- 238000005694 sulfonylation reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Images
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010605771 CN102070626B (zh) | 2010-12-11 | 2010-12-11 | 一种制备伊潘立酮的新方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010605771 CN102070626B (zh) | 2010-12-11 | 2010-12-11 | 一种制备伊潘立酮的新方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201310001504 Division CN103086931A (zh) | 2010-12-11 | 2010-12-11 | 一种制备伊潘立酮的新方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102070626A true CN102070626A (zh) | 2011-05-25 |
CN102070626B CN102070626B (zh) | 2013-02-13 |
Family
ID=44029406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010605771 Active CN102070626B (zh) | 2010-12-11 | 2010-12-11 | 一种制备伊潘立酮的新方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102070626B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101735208A (zh) * | 2009-12-08 | 2010-06-16 | 华东师范大学 | 一种伊潘立酮的合成方法 |
CN101768154A (zh) * | 2009-09-19 | 2010-07-07 | 浙江华海药业股份有限公司 | 一种新的依潘立酮的制备方法 |
CN101781243A (zh) * | 2009-01-20 | 2010-07-21 | 天津药物研究院 | 医药中间体、其制备方法和用其制备伊潘立酮的方法 |
CN101824030A (zh) * | 2009-03-04 | 2010-09-08 | 北京德众万全药物技术开发有限公司 | 一种伊潘立酮的制备方法 |
-
2010
- 2010-12-11 CN CN 201010605771 patent/CN102070626B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101781243A (zh) * | 2009-01-20 | 2010-07-21 | 天津药物研究院 | 医药中间体、其制备方法和用其制备伊潘立酮的方法 |
CN101824030A (zh) * | 2009-03-04 | 2010-09-08 | 北京德众万全药物技术开发有限公司 | 一种伊潘立酮的制备方法 |
CN101768154A (zh) * | 2009-09-19 | 2010-07-07 | 浙江华海药业股份有限公司 | 一种新的依潘立酮的制备方法 |
CN101735208A (zh) * | 2009-12-08 | 2010-06-16 | 华东师范大学 | 一种伊潘立酮的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102070626B (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI404715B (zh) | 二芳基醚脲化合物 | |
WO2018045911A1 (zh) | 二氢嘧啶类化合物及其制备方法和用途 | |
CN103030668B (zh) | 一种制备福沙匹坦二甲葡胺的方法 | |
CN109438405A (zh) | 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法 | |
CN113773304A (zh) | 抗耐药抗肿瘤egfr抑制剂的制备方法 | |
TWI258470B (en) | Process for preparing aripiprazole | |
CN102190628B (zh) | 一种5-氟-6-乙基-4-羟基嘧啶中间体及伏立康唑的制备方法 | |
CN105712984A (zh) | 一种阿齐沙坦的制备方法 | |
CN103819450B (zh) | 一种苯甲酸阿格列汀的新制备方法 | |
EP2276735A1 (en) | Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors | |
EP2722330A1 (en) | Novel method for synthesizing rivaroxaban intermediate, 4-{4-[(5s)-5-(aminomethyl)-2-oxo-1,3-oxazoligdin-3-yl]phenyl}morpholin-3-one | |
CN111606889A (zh) | 4-(1-环丙基-1h-吲哚-3-基)-n-苯基嘧啶-2-胺衍生物的制备方法 | |
JPH04234878A (ja) | ヘテロサイクルにより置換されたジヒドロピリジン類 | |
CN1986535A (zh) | 罗沙替丁醋酸酯盐酸盐的合成方法 | |
KR102027388B1 (ko) | 고순도 일라프라졸 결정형 b의 제조방법 | |
CN1026489C (zh) | 抗鼻病毒的(硫代)吗啉基和哌嗪基烷基酚醚的制备方法 | |
RU2164226C2 (ru) | Производные 5-(гидроксиметил)-оксазолидин-2-она, способы их получения, лекарство и фармацевтический состав | |
CN102070626B (zh) | 一种制备伊潘立酮的新方法 | |
CN102796090B (zh) | 一种伊潘立酮的制备方法 | |
CN102977142A (zh) | 福沙匹坦二甲葡胺的制备方法 | |
CA3148365A1 (en) | Alpha-d-galactopyranoside derivatives | |
CN102212063A (zh) | 一种伊潘立酮的制备方法 | |
CN103922925B (zh) | 一种非诺贝酸的生产工艺 | |
CN103086931A (zh) | 一种制备伊潘立酮的新方法 | |
CN111423362A (zh) | 两种高纯度丁酸氯维地平杂质的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Novel method of preparing iloperidone Effective date of registration: 20170405 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: HAINAN KANGHONG MEDICAL TECHNOLOGY DEVELOPMENT CO.,LTD. Registration number: 2017460000004 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180521 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: HAINAN KANGHONG MEDICAL TECHNOLOGY DEVELOPMENT CO.,LTD. Registration number: 2017460000004 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Novel method of preparing iloperidone Effective date of registration: 20180523 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: HAINAN KANGHONG MEDICAL TECHNOLOGY DEVELOPMENT CO.,LTD. Registration number: 2018460000003 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190729 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: HAINAN KANGHONG MEDICAL TECHNOLOGY DEVELOPMENT CO.,LTD. Registration number: 2018460000003 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Novel method of preparing iloperidone Effective date of registration: 20190808 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: HAINAN KANGHONG MEDICAL TECHNOLOGY DEVELOPMENT CO.,LTD. Registration number: Y2019460000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP03 | Change of name, title or address |
Address after: No. 33, Xiaxian 1st Village, Meilan District, Haikou City, Hainan Province Patentee after: Hainan Qirong Information Technology Co.,Ltd. Address before: Xiuying District East Ocean Road 570311 Hainan city of Haikou province No. 4 standard factory building three layer Patentee before: HAINAN KANGHONG MEDICAL TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200520 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: HAINAN KANGHONG MEDICAL TECHNOLOGY DEVELOPMENT Co.,Ltd. Registration number: Y2019460000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Novel method of preparing iloperidone Effective date of registration: 20200528 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: Hainan Qirong Information Technology Co.,Ltd. Registration number: Y2020980002573 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210701 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: Hainan Qirong Information Technology Co.,Ltd. Registration number: Y2020980002573 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A new method for preparation of eparenone Effective date of registration: 20210705 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: Hainan Qirong Information Technology Co.,Ltd. Registration number: Y2021980005697 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230328 Address after: Room 1506, Building B, Jinghai Garden, No. 1, Haidian Island Sandong Road, Haidian Street, Meilan District, Haikou City, Hainan Province, 570100 Patentee after: Ge Yabo Address before: No. 33, Xiaxianyi Village, Meilan District, Haikou City, Hainan Province, 570100 Patentee before: Hainan Qirong Information Technology Co.,Ltd. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230608 Granted publication date: 20130213 Pledgee: China Everbright Bank Co.,Ltd. Haikou Branch Pledgor: Hainan Qirong Information Technology Co.,Ltd. Registration number: Y2021980005697 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |